1) chromosome 17
17号染色体
1.
The purpose of this study is to investigate the status of p16 gene deletion and chromosome 17 aneuploidy change in EGIST and the relationship with p16 and p53 protein expression, and to analyse the correlation between the three types of multi-drug resistance gene product(P-gp,GST-πand TopoⅡ),to provide valuable reference information for related drug treatment of EGIST after operation.
本研究旨在探讨p16基因缺失及17号染色体的非整倍性改变在EGIST中的发生情况,并进一步研究二者的改变与p16、p53蛋白表达之间的关系以及与三种多药耐药基因产物(P-gp、GST-π和TopoⅡ)的相关性分析,为EGIST预后及术后应用相关药物治疗提供有价值的参考信息。
2.
Chromosome 17 polysomy was correlated to HER2 protein expression(P<0.
目的:比较免疫组织化学法(IHC)、荧光原位杂交法(FISH)与显色原位杂交法(CISH)检测乳腺癌HER2基因状态的一致性,探讨FISH法与CISH法检测乳腺癌HER2基因状态的临床意义、FISH法检测17号染色体多体的发生情况及其意义。
4) Chromosome 1
1号染色体
1.
Transcriptional Analysis of Chromosome 1 in Diffuse Large B-Cell Lymphoma;
弥漫大B细胞淋巴瘤1号染色体的基因表达分析
2.
Linkage analysis of susceptibility genes for familial schizophrenia on chromosome 1 in Chinese population;
中国人群中家族性精神分裂症与1号染色体的连锁分析
3.
Objective To explore the molecular genetic relationship between chromosome 1 and quantitative trait loci for familial schizophrenia.
目的 探讨家族性精神分裂症的定量性状位点与 1号染色体的分子遗传学关系。
5) Chromosome 9
9号染色体
1.
Genetic Effect of Pericentric Inversion of Chromosome 9;
9号染色体臂间倒位的遗传效应研究
2.
Genetic polymorphism of 10 STR loci on chromosome 9 and its forensic application in Chinese population;
中国人群9号染色体10个STR基因座的遗传多态性及其在法医学中的应用
3.
To understand the genetic polymorphism of 10 STR loci on chromosome 9 and reveal the difference on the linkage maps of different populations, the author used a set of nine tetranucleotide ?and one tritranucleotide repeat STR markers on chromosome 9 chosen from Genome Data Bank.
18个无关汉族 3代家系共 131份血样采自甘肃省白银地区 ,常规PCR扩增 9号染色体的 10个STR基因座 ,采用非变性聚丙烯酰胺凝胶电泳分析。
6) Chromosome 7
7号染色体
1.
Analysis of Pericentric Inversion of Chromosome 7 Associated with Turner Syndrome in Family;
7号染色体臂间倒位伴Turner综合征家系分析(英文)
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条